Abstract Mephentermine, a stimulant drug, is used as vasoconstrictor to maintain blood pressure in hypotensive states and shock, but due to its stimulant effects on the central nervous system, it has also been used for performance enhancement by athletes. Here, we discuss three cases where the patients had used mephentermine to enhance their work performance. Case 1: A male in his 30’s, presented with palpitation, headache, and hypertension after 1 year of use of mephentermine which he had started using with the purpose of increasing his work performance. Case 2: A 22-year-old male presented with depressive symptoms following a 3-year history of use of mephentermine after being suggested by peers to enhance performance at gym. Case 3: A 22-year-old male with 2-year history of mephentermine, presented with withdrawal symptoms, after being introduced to mephentermine by his peers to improve physical performance and difficulty stopping its use on his own. It was found that the purpose of mephentermine abuse in all three discussed cases was to enhance performance, either at sports or workplace, which gradually lead to physical or mental complications or withdrawal symptoms. It thus seems imperative to create awareness about the harmful and addictive effects of mephentermine to masses, and simultaneously limiting its easy availability.
{"title":"“Mephentermine Abuse” an Age-old Concern with New Challenges: Review of Literature with Case Series","authors":"Yogender Kumar Malik, Akansha Bhardwaj, Adwitiya Ray, Bhumika Malik, Rajiv Gupta","doi":"10.4103/aip.aip_59_23","DOIUrl":"https://doi.org/10.4103/aip.aip_59_23","url":null,"abstract":"Abstract Mephentermine, a stimulant drug, is used as vasoconstrictor to maintain blood pressure in hypotensive states and shock, but due to its stimulant effects on the central nervous system, it has also been used for performance enhancement by athletes. Here, we discuss three cases where the patients had used mephentermine to enhance their work performance. Case 1: A male in his 30’s, presented with palpitation, headache, and hypertension after 1 year of use of mephentermine which he had started using with the purpose of increasing his work performance. Case 2: A 22-year-old male presented with depressive symptoms following a 3-year history of use of mephentermine after being suggested by peers to enhance performance at gym. Case 3: A 22-year-old male with 2-year history of mephentermine, presented with withdrawal symptoms, after being introduced to mephentermine by his peers to improve physical performance and difficulty stopping its use on his own. It was found that the purpose of mephentermine abuse in all three discussed cases was to enhance performance, either at sports or workplace, which gradually lead to physical or mental complications or withdrawal symptoms. It thus seems imperative to create awareness about the harmful and addictive effects of mephentermine to masses, and simultaneously limiting its easy availability.","PeriodicalId":52916,"journal":{"name":"Annals of Indian Psychiatry","volume":"103 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134980107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Telemedicine in India: COVID-19 and beyond?","authors":"Shivakumar Kumar, G. Pranathi","doi":"10.4103/aip.aip_73_22","DOIUrl":"https://doi.org/10.4103/aip.aip_73_22","url":null,"abstract":"","PeriodicalId":52916,"journal":{"name":"Annals of Indian Psychiatry","volume":"7 1","pages":"83 - 84"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45501347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kashish Thaper, M. Datar, J. Shetty, Anshumi Bhattacharya
Background: Health-care workers (HCWs) working in COVID care are vulnerable to various psychological stressors. The novel nature of infection and exponential increase in cases add to the workload and psychological distress. Hence, assessing the psychological consequences and methods of coping in these HCWs is important. The detection can help in devising appropriate psychological interventions for them. Aim: The aim of this study was to assess the psychological reactions, symptoms, and coping strategies of HCWs in COVID section of a tertiary hospital. Objectives: The objectives of this study were as follows: (1) to explore various psychological reactions, stressors, psychological symptoms, and coping skills of doctors, nurses, and support staff working in COVID section of a tertiary care hospital and (2) to correlate the psychological reactions, stressors, and psychological symptoms with sociodemographic factors. Methodology: This was a qualitative study. A total of 100 HCWs including doctors, nurses, and support staff working in COVID section of hospital were interviewed for psychological consequences and their coping strategies. Their narratives were coded into themes and analyzed. Statistical Analysis: Frequency and percentages for quantitative variables were used for statistical analysis. Chi-square test was used for correlation of qualitative variables. Results: The HCWs reported various psychological reactions of worries about their own health which was significant in HCWs in intensive care unit (χ2 = 12.35, P = 0.002) and had concern of nature of work, which was a significant concern in doctors (χ2 = 9.59, P = 0.008). The stressor of uncomfortable personal protective equipment was found to be reported more significantly by support staff (chi2 = 11.1, P = 0.03), and that of long and burdensome work reported more significantly by females (chi2 = 4.64, P = 0.03). They had prominent psychological symptoms of irritability significantly reported by doctors (χ2 = 9.91, P = 0.007), sleep disturbances significantly reported by unmarried (χ2 = 6.76, P = 0.009), and by nurses (χ2 = 9.7, P = 0.008). The most common coping strategies used were acceptance, problem-solving strategies, and communicating with family members and colleagues. Conclusion: The HCWs in COVID section had stressors with psychological reactions and symptoms and used various coping strategies to deal with them.
{"title":"Psychological consequences and coping strategies of health-care workers in COVID section of a tertiary hospital: A qualitative study","authors":"Kashish Thaper, M. Datar, J. Shetty, Anshumi Bhattacharya","doi":"10.4103/aip.aip_125_21","DOIUrl":"https://doi.org/10.4103/aip.aip_125_21","url":null,"abstract":"Background: Health-care workers (HCWs) working in COVID care are vulnerable to various psychological stressors. The novel nature of infection and exponential increase in cases add to the workload and psychological distress. Hence, assessing the psychological consequences and methods of coping in these HCWs is important. The detection can help in devising appropriate psychological interventions for them. Aim: The aim of this study was to assess the psychological reactions, symptoms, and coping strategies of HCWs in COVID section of a tertiary hospital. Objectives: The objectives of this study were as follows: (1) to explore various psychological reactions, stressors, psychological symptoms, and coping skills of doctors, nurses, and support staff working in COVID section of a tertiary care hospital and (2) to correlate the psychological reactions, stressors, and psychological symptoms with sociodemographic factors. Methodology: This was a qualitative study. A total of 100 HCWs including doctors, nurses, and support staff working in COVID section of hospital were interviewed for psychological consequences and their coping strategies. Their narratives were coded into themes and analyzed. Statistical Analysis: Frequency and percentages for quantitative variables were used for statistical analysis. Chi-square test was used for correlation of qualitative variables. Results: The HCWs reported various psychological reactions of worries about their own health which was significant in HCWs in intensive care unit (χ2 = 12.35, P = 0.002) and had concern of nature of work, which was a significant concern in doctors (χ2 = 9.59, P = 0.008). The stressor of uncomfortable personal protective equipment was found to be reported more significantly by support staff (chi2 = 11.1, P = 0.03), and that of long and burdensome work reported more significantly by females (chi2 = 4.64, P = 0.03). They had prominent psychological symptoms of irritability significantly reported by doctors (χ2 = 9.91, P = 0.007), sleep disturbances significantly reported by unmarried (χ2 = 6.76, P = 0.009), and by nurses (χ2 = 9.7, P = 0.008). The most common coping strategies used were acceptance, problem-solving strategies, and communicating with family members and colleagues. Conclusion: The HCWs in COVID section had stressors with psychological reactions and symptoms and used various coping strategies to deal with them.","PeriodicalId":52916,"journal":{"name":"Annals of Indian Psychiatry","volume":"7 1","pages":"17 - 24"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48693335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shri Gopal Goyal, Prem Prakash, Suresh Parihar, K. K. Verma
Abstract Background: Headache is one of the most common complaints seen among the patients attending the psychiatric outpatient department. Psychiatric comorbidities worsen the headache and there is a vicious cycle of headache and psychiatric symptoms, aggravating each other. This further complicates headache management so it is better to explore psychiatric symptoms whenever we come across a headache patient. Aims and Objectives: The aim and objective of the study are to assess the psychiatric comorbidities and disability among the patients complaining of headaches. Materials and Methods: This was a cross-sectional study carried out at a tertiary care center. Patients attending the outpatient department with complaints of headaches were enrolled. Psychiatric comorbidities were assessed by using patient health questionnaire-9, generalized anxiety disorder-7 scale, depression, anxiety, and stress 21 scale along with allodynia symptom checklist-12. Disability in the past 3 months was assessed by Migraine Disability Assessment Scale (MIDAS) scale. A semi-structured Performa was used to record sociodemographic details and clinical variables. Results: Majority of the patients (69%) were of the age group 20–40 years. Females (75%) predominated in the study. The average severity of headaches reported by 63% of patients was moderate over Likert’s scale. Temple area (73%) was the main location. Throbbing (81%) was the main type of headache. One-third of the patients got compelled to wake at night due to headache attacks. The main premonitory symptoms were depression, irritability, and sensitivity to sound. Other associated symptoms during headache attacks were sensitivity to sound, anxiety, and irritability. Psychological stress was the main provoking factor. The majority of patients (75%) show mild disability in the past 3 months over the MIDAS scale. 25% of the patient-reported moderate depression over the patient health questionare-9 scale. The majority of the patients (85%) reported moderate-to-severe anxiety and nearly half of the patients reported severe stress. Conclusion: Patients with headaches have high chances of associated psychiatric comorbidities that make worse outcomes of each other so it is better to do detailed psychiatric workup and treat them efficiently keeping in view of psychiatric symptoms.
{"title":"Assessment of Psychiatric Comorbidities and Disability in Patients with a Complaint of Headache Attending Psychiatric Outpatient Department at Tertiary Care Center","authors":"Shri Gopal Goyal, Prem Prakash, Suresh Parihar, K. K. Verma","doi":"10.4103/aip.aip_146_21","DOIUrl":"https://doi.org/10.4103/aip.aip_146_21","url":null,"abstract":"Abstract Background: Headache is one of the most common complaints seen among the patients attending the psychiatric outpatient department. Psychiatric comorbidities worsen the headache and there is a vicious cycle of headache and psychiatric symptoms, aggravating each other. This further complicates headache management so it is better to explore psychiatric symptoms whenever we come across a headache patient. Aims and Objectives: The aim and objective of the study are to assess the psychiatric comorbidities and disability among the patients complaining of headaches. Materials and Methods: This was a cross-sectional study carried out at a tertiary care center. Patients attending the outpatient department with complaints of headaches were enrolled. Psychiatric comorbidities were assessed by using patient health questionnaire-9, generalized anxiety disorder-7 scale, depression, anxiety, and stress 21 scale along with allodynia symptom checklist-12. Disability in the past 3 months was assessed by Migraine Disability Assessment Scale (MIDAS) scale. A semi-structured Performa was used to record sociodemographic details and clinical variables. Results: Majority of the patients (69%) were of the age group 20–40 years. Females (75%) predominated in the study. The average severity of headaches reported by 63% of patients was moderate over Likert’s scale. Temple area (73%) was the main location. Throbbing (81%) was the main type of headache. One-third of the patients got compelled to wake at night due to headache attacks. The main premonitory symptoms were depression, irritability, and sensitivity to sound. Other associated symptoms during headache attacks were sensitivity to sound, anxiety, and irritability. Psychological stress was the main provoking factor. The majority of patients (75%) show mild disability in the past 3 months over the MIDAS scale. 25% of the patient-reported moderate depression over the patient health questionare-9 scale. The majority of the patients (85%) reported moderate-to-severe anxiety and nearly half of the patients reported severe stress. Conclusion: Patients with headaches have high chances of associated psychiatric comorbidities that make worse outcomes of each other so it is better to do detailed psychiatric workup and treat them efficiently keeping in view of psychiatric symptoms.","PeriodicalId":52916,"journal":{"name":"Annals of Indian Psychiatry","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134980343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstract Chronic mania is a known but underexplored entity and still lacks nosological status. Earlier reports of chronic mania have found distinct symptomatology, course, outcome, and treatment challenges. Three cases of chronic mania are presented with challenges in treatment, variable response to drugs and different outcomes along with a synopsis of review of literature in this context. There is a need for longitudinal follow-up studies of patients with diagnosis suggestive of chronic mania for better understanding of treatment response and outcome.
{"title":"Chronic Mania: A Case Series","authors":"Priyanka Hooda, Bhupendra Khobragade, Ananya Mahapatra, Shipra Singh","doi":"10.4103/aip.aip_109_21","DOIUrl":"https://doi.org/10.4103/aip.aip_109_21","url":null,"abstract":"Abstract Chronic mania is a known but underexplored entity and still lacks nosological status. Earlier reports of chronic mania have found distinct symptomatology, course, outcome, and treatment challenges. Three cases of chronic mania are presented with challenges in treatment, variable response to drugs and different outcomes along with a synopsis of review of literature in this context. There is a need for longitudinal follow-up studies of patients with diagnosis suggestive of chronic mania for better understanding of treatment response and outcome.","PeriodicalId":52916,"journal":{"name":"Annals of Indian Psychiatry","volume":"2016 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134980351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstract Background: Treatment-resistant schizophrenia (TRS) is one of the most disabling forms of schizophrenia. The Indian population being different in its sociodemographic factors, clinical profiles, and family structures, the experience of the efficacy of clozapine here is insufficient. Aim: The aim of the study is to explore the efficacy of clozapine in TRS over 3 months of drug use. Materials and Methods: It was an open-label interventional 12-week follow-up study, with 30 consenting adults with TRS determined as per modified Conley and Kelly’s criteria of treatment resistance. The patient’s sociodemographic and clinical details were recorded. Oral clozapine was initiated with gradual up-titration after preclozapine workup. The Positive and Negative Syndrome Scale (PANSS) score was assessed at baseline and reviewed at 4 weekly intervals. Results: By the end of 12 weeks, on an average dose of 494 ± 113.83 mg/day, 36.67% of patients reported 25%–50% improvement in PANSS score. The maximum improvement was seen in the positive symptoms subscale followed by the general and negative symptoms subscale. Conclusion: This study enlightens the dosage differences and efficacy of clozapine in the management of TRS in the Indian population.
{"title":"Efficacy of Clozapine in Patients with Schizophrenia – A 3-Month follow-up Study from North India","authors":"Paramvir Singh, Yesh Chandra Singh, Abhinav Pandey, Chitrakshee Singh, Nirali Muchhala, Sagar Karia","doi":"10.4103/aip.aip_89_23","DOIUrl":"https://doi.org/10.4103/aip.aip_89_23","url":null,"abstract":"Abstract Background: Treatment-resistant schizophrenia (TRS) is one of the most disabling forms of schizophrenia. The Indian population being different in its sociodemographic factors, clinical profiles, and family structures, the experience of the efficacy of clozapine here is insufficient. Aim: The aim of the study is to explore the efficacy of clozapine in TRS over 3 months of drug use. Materials and Methods: It was an open-label interventional 12-week follow-up study, with 30 consenting adults with TRS determined as per modified Conley and Kelly’s criteria of treatment resistance. The patient’s sociodemographic and clinical details were recorded. Oral clozapine was initiated with gradual up-titration after preclozapine workup. The Positive and Negative Syndrome Scale (PANSS) score was assessed at baseline and reviewed at 4 weekly intervals. Results: By the end of 12 weeks, on an average dose of 494 ± 113.83 mg/day, 36.67% of patients reported 25%–50% improvement in PANSS score. The maximum improvement was seen in the positive symptoms subscale followed by the general and negative symptoms subscale. Conclusion: This study enlightens the dosage differences and efficacy of clozapine in the management of TRS in the Indian population.","PeriodicalId":52916,"journal":{"name":"Annals of Indian Psychiatry","volume":"305 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134980358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Guilt: The concept and facets seen in clinical practice","authors":"A. De Sousa","doi":"10.4103/aip.aip_81_23","DOIUrl":"https://doi.org/10.4103/aip.aip_81_23","url":null,"abstract":"","PeriodicalId":52916,"journal":{"name":"Annals of Indian Psychiatry","volume":"7 1","pages":"1 - 3"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45158877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ankit Halder, N. Ravindran, Dinobandhu Naga, Sarthak M. Keshri
Stevens-Johnson syndrome is an acute, rare, and potentially fatal skin reactions involving loss of skin and, in some cases, mucosal membranes. Medications are causative in majority of them. Here in the 3 cases, we found sertraline being the causative agent. Majority of the reports on drug induced SJS in our field is related to lamotrigine and only one case report on sertraline causing such manifestation was found in literature. Immunological modifications are proposed reasons behind the same. So, while prescribing comparatively safer agents like sertraline a clinician should carefully monitor such complications.
{"title":"Sertraline induced Stevens-Johnson syndrome - A case series","authors":"Ankit Halder, N. Ravindran, Dinobandhu Naga, Sarthak M. Keshri","doi":"10.4103/aip.aip_29_23","DOIUrl":"https://doi.org/10.4103/aip.aip_29_23","url":null,"abstract":"Stevens-Johnson syndrome is an acute, rare, and potentially fatal skin reactions involving loss of skin and, in some cases, mucosal membranes. Medications are causative in majority of them. Here in the 3 cases, we found sertraline being the causative agent. Majority of the reports on drug induced SJS in our field is related to lamotrigine and only one case report on sertraline causing such manifestation was found in literature. Immunological modifications are proposed reasons behind the same. So, while prescribing comparatively safer agents like sertraline a clinician should carefully monitor such complications.","PeriodicalId":52916,"journal":{"name":"Annals of Indian Psychiatry","volume":"7 1","pages":"80 - 82"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46576448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstract Background: Diabetes is one of the largest global health emergencies of the 21 st century. As per the International Diabetes Federation (IDF) in 2020, 463 million people have diabetes in the world and 88 million people in the Southeast Asia region. Seventy-seven million out of 88 million belong to India. The prevalence of diabetes in the population is 8.9%, according to the IDF. There exists a bidirectional association between diabetes and depression/anxiety, with both worsening each other’s prognosis. The prevalence rates of depression could be up to three times higher in patients with type 1 diabetes and twice as high in people with type 2 diabetes, while anxiety disorders are seen in 40% of the patients with type 1 or 2 diabetes mellitus. Although no single cause has been identified for the positive correlation between diabetes and depression and anxiety, it is widely accepted that hypothalamic–pituitary–adrenal dysfunction, pro-inflammatory cytokines, and a host of other epigenetic factors are responsible for the increased prevalence. This study was undertaken to check the prevalence of anxiety and depression in patients with diabetes mellitus attending the outdoor clinics of internal medicine department at a district hospital, Fatehgarh Sahib, Punjab. Materials and Methods: Four hundred patients were included in our study. A semi-structured pro forma was used to collect demographic details, and anxiety and depression were screened using the Hamilton Anxiety and Depression Rating Scales, respectively. Data collected were subjected to statistical analysis. Results: Fifty-eight percent of the sample population had depression and 27% had anxiety, with a vast majority having mild symptoms. Gender and duration of diabetes were statistically significant variables affecting prevalence and severity, with females having a higher mean scores of depression and anxiety than males and higher scores with greater duration of the illness. Conclusions: This study implies need for routine screening of depression and anxiety symptoms in patients with diabetes mellitus and treating them at the earliest.
{"title":"Prevalence of Depression and Anxiety in Patients with Diabetes Mellitus at a Secondary Level Government Health-Care Facility in Northern India","authors":"Manpreet Singh, Gagandeep Singh Shergill, Garima Bhatt, Zoya Gill","doi":"10.4103/aip.aip_145_21","DOIUrl":"https://doi.org/10.4103/aip.aip_145_21","url":null,"abstract":"Abstract Background: Diabetes is one of the largest global health emergencies of the 21 st century. As per the International Diabetes Federation (IDF) in 2020, 463 million people have diabetes in the world and 88 million people in the Southeast Asia region. Seventy-seven million out of 88 million belong to India. The prevalence of diabetes in the population is 8.9%, according to the IDF. There exists a bidirectional association between diabetes and depression/anxiety, with both worsening each other’s prognosis. The prevalence rates of depression could be up to three times higher in patients with type 1 diabetes and twice as high in people with type 2 diabetes, while anxiety disorders are seen in 40% of the patients with type 1 or 2 diabetes mellitus. Although no single cause has been identified for the positive correlation between diabetes and depression and anxiety, it is widely accepted that hypothalamic–pituitary–adrenal dysfunction, pro-inflammatory cytokines, and a host of other epigenetic factors are responsible for the increased prevalence. This study was undertaken to check the prevalence of anxiety and depression in patients with diabetes mellitus attending the outdoor clinics of internal medicine department at a district hospital, Fatehgarh Sahib, Punjab. Materials and Methods: Four hundred patients were included in our study. A semi-structured pro forma was used to collect demographic details, and anxiety and depression were screened using the Hamilton Anxiety and Depression Rating Scales, respectively. Data collected were subjected to statistical analysis. Results: Fifty-eight percent of the sample population had depression and 27% had anxiety, with a vast majority having mild symptoms. Gender and duration of diabetes were statistically significant variables affecting prevalence and severity, with females having a higher mean scores of depression and anxiety than males and higher scores with greater duration of the illness. Conclusions: This study implies need for routine screening of depression and anxiety symptoms in patients with diabetes mellitus and treating them at the earliest.","PeriodicalId":52916,"journal":{"name":"Annals of Indian Psychiatry","volume":"280 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134980363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Individual sleep and activity patterns show large variations and are interfered considerably by social schedules. Social jetlag (SJL) is the difference between intrinsic circadian rhythm and extrinsically enforced sleep-wake cycle. However, little is known about the variables affecting the severity of SJL. Methodology: We evaluated whether sleep- or smartphone-related variables affected the severity of SJL among college students in India. A total of 1175 students from medicine, dental, engineering, paramedical, and other colleges in Gujarat, India, completed a web-based survey. The survey included demographic questions and questions from the Smartphone Addiction Scale-Short Version (SAS-SV), reduced Horne and Ostberg Morningness-Eveningness Questionnaire (rMEQ), and Munich Chronotype Questionnaire (MCTQ). The responses to the MCTQ determined SJL scores. Results: Outcomes from multiple linear regression analysis indicated that the sleep length on free-day (B = 0.42), chronotypes (B = 0.44, B2 = 0.40) maximum smartphone usage time after waking up (B = 0.92), smartphone addiction severity (B = ‒0.01) and free-day sleep onset range (B = ‒0.02) significantly predicted SJL scores (P < 0.03). The SJL severity was 0.42 and 0.40 units greater in individuals with morning-type and evening-type, respectively, compared to the neutral-type rMEQ category. The SJL severity was 0.92 units greater in individuals whose smartphone usage was maximum right after waking up compared to those whose usage was maximum during other times of the day. Every unit increase in SAS score decreased SJL by 0.01 units. Conclusion: These results indicate that SJL severity is affected by several factors, which can be targeted for developing interventions for reducing SJL among college students in India.
{"title":"Evaluation of smartphone usage as a predictor of social jetlag in university students","authors":"Karan Mehta, Neeraj Mahajan, Dishant B. Upadhyay, Taxashil Jadeja, Rajkumar J Sevak","doi":"10.4103/aip.aip_24_22","DOIUrl":"https://doi.org/10.4103/aip.aip_24_22","url":null,"abstract":"Background: Individual sleep and activity patterns show large variations and are interfered considerably by social schedules. Social jetlag (SJL) is the difference between intrinsic circadian rhythm and extrinsically enforced sleep-wake cycle. However, little is known about the variables affecting the severity of SJL. Methodology: We evaluated whether sleep- or smartphone-related variables affected the severity of SJL among college students in India. A total of 1175 students from medicine, dental, engineering, paramedical, and other colleges in Gujarat, India, completed a web-based survey. The survey included demographic questions and questions from the Smartphone Addiction Scale-Short Version (SAS-SV), reduced Horne and Ostberg Morningness-Eveningness Questionnaire (rMEQ), and Munich Chronotype Questionnaire (MCTQ). The responses to the MCTQ determined SJL scores. Results: Outcomes from multiple linear regression analysis indicated that the sleep length on free-day (B = 0.42), chronotypes (B = 0.44, B2 = 0.40) maximum smartphone usage time after waking up (B = 0.92), smartphone addiction severity (B = ‒0.01) and free-day sleep onset range (B = ‒0.02) significantly predicted SJL scores (P < 0.03). The SJL severity was 0.42 and 0.40 units greater in individuals with morning-type and evening-type, respectively, compared to the neutral-type rMEQ category. The SJL severity was 0.92 units greater in individuals whose smartphone usage was maximum right after waking up compared to those whose usage was maximum during other times of the day. Every unit increase in SAS score decreased SJL by 0.01 units. Conclusion: These results indicate that SJL severity is affected by several factors, which can be targeted for developing interventions for reducing SJL among college students in India.","PeriodicalId":52916,"journal":{"name":"Annals of Indian Psychiatry","volume":"7 1","pages":"54 - 59"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45039178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：